Trial Combining Pembrolizumab and Cesium 131 Brachytherapy With Salvage Surgery in HNSCC

Condition:   HNSCC Interventions:   Device: Cesium-131;   Drug: Pembrolizumab Sponsors:   University of Cincinnati;   IsoRay Medical, Inc. Not yet recruiting

Source: ClinicalTrials.gov - April 9, 2020 Category: Research Source Type: clinical trials